CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Asthma - Management
Long-acting beta2-agonist
- Do not prescribe a long-acting beta2 agonist (LABAs) for someone who is not already using an ICS.
- Do not stop inhaled corticosteroid treatment whilst an individual is using a LABA.
- Do not start anyone with acutely deteriorating asthma on LABA therapy.
- Closely monitor anyone started on an LABA, especially during the first 3 months of treatment.
- Only continue therapy with LABAs if they have shown benefit.
- Advise people who have been prescribed salmeterol that they should not use it to relieve an acute asthma attack.
For full details see Prescribing information.
© NHS Institute for Innovation and Improvement